Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) just unveiled an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced that there have been no significant developments in the bankruptcy liquidation proceedings of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since the last update. The company remains committed to monitoring the situation closely, maintaining communication with relevant parties, and safeguarding shareholder interests, while continuing to provide monthly updates as per regulatory requirements.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, operates in the pharmaceutical industry. The company, along with its subsidiaries, focuses on the development and production of pharmaceutical products in the People’s Republic of China.
For a thorough assessment of 2TZ stock, go to TipRanks’ Stock Analysis page.